Trexquant Investment’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-223,121
| Closed | -$2.03M | – | 1870 |
|
|
2025
Q2 | $2.03M | Sell |
223,121
-410,504
| -65% | -$3.02M | 0.02% | 879 |
|
|
2025
Q1 | $5.04M | Buy |
633,625
+488,963
| +338% | +$3.58M | 0.06% | 500 |
|
|
2024
Q4 | $786K | Sell |
144,662
-30,999
| -18% | -$190K | 0.01% | 1175 |
|
|
2024
Q3 | $1.27M | Sell |
175,661
-139,582
| -44% | -$1.28M | 0.02% | 968 |
|
|
2024
Q2 | $3.42M | Buy |
315,243
+287,385
| +1,032% | +$3.68M | 0.05% | 534 |
|
|
2024
Q1 | $522K | Sell |
27,858
-75,239
| -73% | -$1.74M | 0.01% | 1130 |
|
|
2023
Q4 | $2.23M | Buy |
+103,097
| New | +$2.04M | 0.05% | 513 |
|
|
2023
Q1 | – | Sell |
-20,249
| Closed | -$772K | – | 1726 |
|
|
2022
Q4 | $772K | Sell |
20,249
-1,345
| -6% | -$51.4K | 0.02% | 750 |
|
|
2022
Q3 | $846K | Buy |
+21,594
| New | +$835K | 0.03% | 591 |
|
|
2022
Q1 | – | Sell |
-6,599
| Closed | -$281K | – | 1672 |
|
|
2021
Q4 | $281K | Buy |
+6,599
| New | +$276K | 0.02% | 959 |
|
|
2020
Q2 | – | Sell |
-24,897
| Closed | -$715K | – | 1432 |
|
|
2020
Q1 | $715K | Buy |
+24,897
| New | +$1.44M | 0.05% | 526 |
|
|
2019
Q1 | – | Sell |
-2,164
| Closed | -$207K | – | 1278 |
|
|
2018
Q4 | $207K | Sell |
2,164
-1,359
| -39% | -$156K | 0.01% | 906 |
|
|
2018
Q3 | $498K | Sell |
3,523
-16,682
| -83% | -$2.57M | 0.04% | 539 |
|
|
2018
Q2 | $3.16M | Buy |
+20,205
| New | +$3.17M | 0.22% | 155 |
|
|
2017
Q2 | – | Sell |
-6,108
| Closed | -$434K | – | 1121 |
|
|
2017
Q1 | $434K | Sell |
6,108
-3,792
| -38% | -$222K | 0.06% | 595 |
|
|
2016
Q4 | $505K | Sell |
9,900
-7,900
| -44% | -$372K | 0.08% | 429 |
|
|
2016
Q3 | $820K | Buy |
+17,800
| New | +$725K | 0.18% | 166 |
|
|
2015
Q2 | – | Sell |
-25,815
| Closed | -$1.3M | – | 1207 |
|
|
2015
Q1 | $1.3M | Buy |
+25,815
| New | +$1.11M | 0.13% | 261 |
|
Other funds holding SAGE
IA
HNB
Trexquant Investment's SAGE Position: Q3 2025 in Review
Trexquant Investment sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 223,121 shares — an estimated $2.03M sold.
Trexquant Investment first reported a position in SAGE in Q1 2015 and held it in 18 quarters. The position peaked at $5.04M in Q1 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Trexquant Investment reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Trexquant Investment sold 223,121 Sage Therapeutics shares in Q3 2025, an estimated $2.03M.
- Trexquant Investment first reported a position in Sage Therapeutics in Q1 2015 and held it in 18 quarters.
- Trexquant Investment's Sage Therapeutics position peaked at $5.04M in Q1 2025.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.